CAPTRUST Financial Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-563	Closed	-$11K	–	5050
2021 Q3	$11K	Buy	563 +474	+533%	+$13.1K	﹤0.01%	3584
2021 Q2	$3K	Buy	89 +13	+17%	+$398	﹤0.01%	4091
2021 Q1	$2K	Buy	+76	New	+$1.94K	﹤0.01%	4108

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

CAPTRUST Financial Advisors's DRNA Position: Q4 2021 in Review

CAPTRUST Financial Advisors sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 563 shares — an estimated $11K sold.

CAPTRUST Financial Advisors first reported a position in DRNA in Q1 2021 and held it in 3 quarters. The position peaked at $11K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

CAPTRUST Financial Advisors reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
CAPTRUST Financial Advisors sold 563 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $11K.
CAPTRUST Financial Advisors first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2021 and held it in 3 quarters.
CAPTRUST Financial Advisors's Dicerna Pharmaceuticals, Inc. position peaked at $11K in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.